ラノラジン二塩酸塩
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01COBQC-3846 |
ラノラジン二塩酸塩
Ranolazine dihydrochloride |
95635-56-6 |
250mg |
￥14500 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01COBQC-3846 |
ラノラジン二塩酸塩
Ranolazine dihydrochloride |
95635-56-6 |
1g |
￥36500 |
2024-03-01 |
購入 |
|
東京化成工業
|
R0112 |
ラノラジン二塩酸塩 >98.0%(HPLC)(T)
Ranolazine Dihydrochloride
>98.0%(HPLC)(T) |
95635-56-6 |
1g |
￥9300 |
2024-03-01 |
購入 |
|
東京化成工業
|
R0112 |
ラノラジン二塩酸塩 >98.0%(HPLC)(T)
Ranolazine Dihydrochloride
>98.0%(HPLC)(T) |
95635-56-6 |
5g |
￥31700 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
R6152 |
ラノラジン 二塩酸塩 ≥98% (HPLC), powder
Ranolazine dihydrochloride ≥98% (HPLC), powder |
95635-56-6 |
100mg |
￥51200 |
2024-03-01 |
購入 |
ラノラジン二塩酸塩 化学特性,用途語,生産方法
外観
白色～ほとんど白色粉末～結晶
効能
血管拡張薬
化学的特性
White Crystalline Powder
使用
Ranolazine Dihydrochloride is an anti-ischemic agent which modulates myocardial metabolism. Antianginal.
生物活性
Antianginal agent with antiarrhythmic properties that acts as a partial fatty acid oxidation inhibitor. Activates pyruvate dehydrogenase in ischemic myocytes to promote glucose oxidation, switching substrate utilization from fatty acids to glucose. Also shown to inhibit late I Na and I Kr currents.
ラノラジン二塩酸塩 上流と下流の製品情報
原材料
準備製品
ラノラジン二塩酸塩 生産企業
Global( 251)Suppliers
95635-56-6(ラノラジン二塩酸塩)キーワード:
- 95635-56-6
- (+/-)-4-[2-HYDROXY-3-(O-METHOXYPHENOXY)PROPYL]-1-PIPERAZINEACETO-2',6'-XYLIDIDE DIHYDROCHLORIDE
- n-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide dihydrochloride
- (+/-)-N-(2,6-DIMETHYLPHENYL)-4-[2-HYDROXY-3-(2-METHOXYPHENOXY)PROPYL]-1-PIPERAZINEACETAMIDE DIHYDROCHLORIDE
- RANOLAZINE DIHYDROCHLORIDE
- RANOLAZINE HCL
- Ranolazine DiHCI
- Ranolazine and salt
- N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)-propyl)piperazin-1-yl)acetamide di
- (±)-N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetamide
- RANOLAZINE DI HCL
- Ranolazine2Hcl
- Ranolazine Dihydrocloride
- N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetamide Dihydrochloride
- RS 43285
- RS 43285-193
- (±) -4-[2-Hydroxy-3-(o-methoxyphenoxy)propyl]-1-piperazineaceto-2μ,6μ-xylidide dihydrochloride, N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetamide dihydrochloride
- N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]ethanamide dihydrochloride
- 1-Piperazineacetamide,N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-, hydrochloride(1:2)
- Ranolazine dihydrochloride,(±) -4-[2-Hydroxy-3-(o-methoxyphenoxy)propyl]-1-piperazineaceto-2′,6′-xylidide dihydrochloride, N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazinea
- Ranolazine dihydroch
- (+/-)-1-[3-(2-Methoxyphenoxy)-2-hydroxypropyl]-4-[(2,6-diMethylphenyl)aMinocarbonylMethyl]piperazine
- (±)-Ranolazine-d8 2HCl
- N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)-propyl)piperazin-1-yl)acetamide dihyd
- Ranolazine dihydrochloride
N-(2,6-Dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide dihydrochloride
- N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide dihydrochloride
- N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazinyl]acetamide dihydrochloride
- Ranolazine Dihydrochloride >
- azine dihydrochL
- Ranolazine dihydrochloride USP/EP/BP
- Ranolazine 2HCl (RS-43285
- ラノラジン二塩酸塩
- 塩酸ラノラジン
- N-(2,6-ジメチルフェニル)-2-{4-[2-ヒドロキシ-3-(2-メトキシフェノキシ)プロピル]ピペラジン-1-イル}アセトアミド
- N-(2,6-ジメチルフェニル)-4-[2-ヒドロキシ-3-(2-メトキシフェノキシ)プロピル]-1-ピペラジンアセトアミド・2塩酸塩
- N-(2,6-ジメチルフェニル)-4-[2-ヒドロキシ-3-(2-メトキシフェノキシ)プロピル]-1-ピペラジンアセトアミド